MAPT and Alzheimer disease: Given an increasing interest in early detection of AD pathology in CU individuals (Ossenkoppele, Pichet Binette, et al., 2022;Rafii et al., 2023;Sperling et al., 2014,2020), it is important to establish whether tau PET MRI-free methods provide consistent results when applied during the early stages of pathological accumulation.